Roche Holding

Roche Holding, headquartered in Basel, Switzerland, is a pioneer in the healthcare industry. Roche is the leading biotech company in the world, with 17 biopharmaceuticals on the market. Biopharmaceuticals make up more than half of the Roche Company's development pipeline, allowing them to provide better-targeted medicines. Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology, and Respiratory Branch Medicines are among their specialties.

Roche is a worldwide leader in medicines and diagnostics dedicated to improving people's lives through science. Roche is the leader in personalised healthcare, a strategy that attempts to match the proper therapy to each patient in the most effective way possible, thanks to the combined powers of pharmaceuticals and diagnostics under one roof.

Roche is the largest biotech firm in the world, offering really unique medications in cancer, immunology, infectious diseases, ophthalmology, and central nervous system illnesses. Roche is also a pioneer in diabetes care and a world leader in in vitro diagnostics and tissue-based cancer diagnostics.

Roche, which was founded in 1896, is still looking for improved methods to prevent, diagnose, and cure illnesses while also contributing to society. By collaborating with all essential parties, the firm also hopes to increase patient access to medical advancements. The World Health Organization Model Lists of Essential Drugs include thirty Roche-developed treatments, including life-saving antibiotics, antimalarials, and cancer medicines. The Dow Jones Sustainability Indices have named Roche the Group Leader in Sustainability in the Pharmaceuticals, Biotechnology, and Life Sciences Industry for the tenth year in a row (DJSI).

Founded: 1896

Headquarters: Basel, Switzerland

Market Cap: 350.650 Billion USD

Website: https://www.roche.com/